Octapeptide repeat region and N-terminal half of hydrophobic region of prion protein (PrP) mediate PrP-dependent activation of superoxide dismutase

被引:47
作者
Sakudo, A
Lee, DC
Nishimura, T
Li, SM
Tsuji, S
Nakamura, T
Matsumoto, Y
Saeki, K
Itohara, S
Ikuta, K
Onodera, T [1 ]
机构
[1] Univ Tokyo, Sch Agr & Life Sci, Dept Mol Immunol, Bunkyo Ku, Tokyo 1138657, Japan
[2] Osaka Univ, Res Inst Microbial Dis, Dept Virol, Suita, Osaka 5650871, Japan
[3] Itoham Cent Res Inst, Kitasoma, Ibaraki 30201, Japan
[4] RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan
关键词
prion disease; prion protein; apoptosis; PrP-deficient cell line;
D O I
10.1016/j.bbrc.2004.11.092
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular prion protein PrPC contains two evolutionarily conserved domains among mammals; viz., the octapeptide repeat region (OR; amino acid residue 51-90) and the hydrophobic region (HR; amino acid residue 112-145). Accumulating evidence indicates that PrPC acts as an inhibitor of apoptosis and regulator of superoxide dismutase (SOD) activity. To further understand how PrPC activates SOD and prevents apoptosis, we provide evidence here that OR and N-terminal half of HR mediate PrPC-dependent SOD activation and anti-apoptotic function. Removal of the OR (amino acid residue 53-94) enhances apoptosis and decreases SOD activity. Deletion of the N-terminal half of HR (amino acids residue 95-132) abolishes its ability to activate SOD and to prevent apoptosis, whereas that of the C-terminal half of HR (amino acids residue 124-146) has little if any effect on the anti-apoptotic activity and SOD activation. These data are consistent with a model in which the anti-apoptotic and anti-oxidative function of PrPC is regulated by not only OR but also the N-terminal half of HR. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:600 / 606
页数:7
相关论文
共 41 条
[1]   Evaluation of quinacrine treatment for prion diseases [J].
Barret, A ;
Tagliavini, F ;
Forloni, G ;
Bate, C ;
Salmona, M ;
Colombo, L ;
De Luigi, A ;
Limido, L ;
Suardi, S ;
Rossi, G ;
Auvré, F ;
Adjou, KT ;
Salès, N ;
Williams, A ;
Lasmézas, C ;
Deslys, JP .
JOURNAL OF VIROLOGY, 2003, 77 (15) :8462-8469
[2]   Prion protein protects human neurons against Bax-mediated apoptosis [J].
Bounhar, Y ;
Zhang, Y ;
Goodyer, CG ;
LeBlanc, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) :39145-39149
[3]   Spongiform encephalopathies - B lymphocytes and neuroinvasion [J].
Brown, P .
NATURE, 1997, 390 (6661) :662-663
[4]   Role of microglia and host prion protein in neurotoxicity of a prion protein fragment [J].
Brown, DR ;
Schmidt, B ;
Kretzschmar, HA .
NATURE, 1996, 380 (6572) :345-347
[5]   Normal prion protein has an activity like that of superoxide dismutase [J].
Brown, DR ;
Wong, BS ;
Hafiz, F ;
Clive, C ;
Haswell, SJ ;
Jones, IM .
BIOCHEMICAL JOURNAL, 1999, 344 :1-5
[6]   MICE DEVOID OF PRP ARE RESISTANT TO SCRAPIE [J].
BUELER, H ;
AGUZZI, A ;
SAILER, A ;
GREINER, RA ;
AUTENRIED, P ;
AGUET, M ;
WEISSMANN, C .
CELL, 1993, 73 (07) :1339-1347
[7]   TRUNCATED FORMS OF THE HUMAN PRION PROTEIN IN NORMAL BRAIN AND IN PRION DISEASES [J].
CHEN, SG ;
TEPLOW, DB ;
PARCHI, P ;
TELLER, JK ;
GAMBETTI, P ;
AUTILIOGAMBETTI, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19173-19180
[8]   Cellular prion protein transduces neuroprotective signals [J].
Chiarini, LB ;
Freitas, ARO ;
Zanata, SM ;
Brentani, RR ;
Martins, VR ;
Linden, R .
EMBO JOURNAL, 2002, 21 (13) :3317-3326
[9]   PRION PROTEIN IS NECESSARY FOR NORMAL SYNAPTIC FUNCTION [J].
COLLINGE, J ;
WHITTINGTON, MA ;
SIDLE, KCL ;
SMITH, CJ ;
PALMER, MS ;
CLARKE, AR ;
JEFFERYS, JGR .
NATURE, 1994, 370 (6487) :295-297
[10]   Mapping the functional domain of the prion protein [J].
Cui, T ;
Daniels, M ;
Wong, BS ;
Li, RL ;
Sy, MS ;
Sassoon, J ;
Brown, DR .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (16) :3368-3376